Progressive Vascular Smooth Muscle Cell Defects in a Mouse Model of Hutchinson-Gilford Progeria Syndrome

Children with Hutchinson-Gilford progeria syndrome (HGPS) suffer from dramatic acceleration of some symptoms associated with normal aging, most notably cardiovascular disease that eventually leads to death from myocardial infarction and/or stroke usually in their second decade of life. For the vast...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 103; no. 9; pp. 3250 - 3255
Main Authors Varga, Renee, Eriksson, Maria, Erdos, Michael R., Olive, Michelle, Harten, Ingrid, Kolodgie, Frank, Capell, Brian C., Cheng, Jun, Faddah, Dina, Perkins, Stacie, Avallone, Hedwig, San, Hong, Qu, Xuan, Ganesh, Santhi, Gordon, Leslie B., Virmani, Renu, Wight, Thomas N., Nabel, Elizabeth G., Collins, Francis S.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 28.02.2006
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Children with Hutchinson-Gilford progeria syndrome (HGPS) suffer from dramatic acceleration of some symptoms associated with normal aging, most notably cardiovascular disease that eventually leads to death from myocardial infarction and/or stroke usually in their second decade of life. For the vast majority of cases, a de novo point mutation in the lamin A (LMNA) gene is the cause of HGPS. This missense mutation creates a cryptic splice donor site that produces a mutant lamin A protein, termed "progerin," which carries a 50-aa deletion near its C terminus. We have created a mouse model for progeria by generating transgenics carrying a human bacterial artificial chromosome that harbors the common HGPS mutation. These mice develop progressive loss of vascular smooth muscle cells in the medial layer of large arteries, in a pattern very similar to that seen in children with HGPS. This mouse model should prove valuable for testing experimental therapies for this devastating disorder and for exploring cardiovascular disease in general.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: R. Varga, M.E., M.R.E., M.O., I.H., F.K., E.G.N., R. Virmani, T.N.W., and F.S.C. designed research; R. Varga, M.E., M.R.E., M.O., I.H., F.K., B.C.C., J.C., D.F., S.P., H.A., H.S., X.Q., and R. Virmani performed research; R. Varga, M.E., M.R.E., M.O., I.H., F.K., B.C.C., H.S., S.G., L.B.G., R. Virmani, T.N.W., E.G.N., and F.S.C. analyzed data; and R. Varga, M.E., M.R.E., M.O., I.H., B.C.C., S.G., L.B.G., T.N.W., E.G.N., and F.S.C. wrote the paper.
Contributed by Francis S. Collins, January 2, 2006
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0600012103